Overview
- Authors:
-
-
Anthony Kales
-
Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, USA
Central Pennsylvania Psychiatric Institute, Pennsylvania State University College of Medicine, Hershey, USA
-
Costas N. Stefanis
-
Department of Psychiatry, Athens University Medical School, Athens, Greece
World Psychiatric Association, USA
-
John A. Talbott
-
Department of Psychiatry, University of Maryland, School of Medicine, Baltimore, USA
Institute of Psychiatry and Human Behavior, University of Maryland Medical System, Baltimore, USA
Access this book
Other ways to access
Table of contents (18 chapters)
-
-
Conceptualization of Schizophrenia
-
-
- Anthony Kales, Joyce D. Kales, Antonio Vela-Bueno
Pages 3-23
-
-
- John M. Cleghorn, Martin L. Albert
Pages 59-80
-
-
- William T. Carpenter Jr., Brian Kirkpatrick, Robert W. Buchanan
Pages 95-113
-
Recent Advances in the Diagnosis and Treatment of Schizophrenia
-
Front Matter
Pages 115-115
-
- Fini Schulsinger, Josef Parnas
Pages 117-129
-
- Lynn E. Delisi, Michael Lovett
Pages 131-161
-
- Jörg J. Pahl, Victor W. Swayze, Nancy C. Andreasen
Pages 163-189
-
-
- Kim T. Mueser, Robert P. Liberman, Shirley M. Glynn
Pages 213-234
-
-
-
Delivery Systems for Managing Schizophrenic Patients
-
Front Matter
Pages 277-277
-
-
-
-
- Nicholas Tarrier, Christine Barrowclough
Pages 331-351
About this book
I am honored to introduce readers to this extraordinary volume, the first in the annual International Perspectives Series: Psychiatry, Psychology, and Neurosciences. This particular volume on the Recent Advances In Schizophrenia stems from the Third Annual Pennsylvania Conference on Schizophrenia, held in March, 1988. At that international meeting, some of the most esteemed researchers in the field surveyed our current under standing of schizophrenia. Collectively, their presentations capture the excitement of a research field launching into a stage of rapid worldwide advancement. The last decade has seen an enormous refocusing of scientific effort on schizophrenia, directed, in large measure, by the National Institute of Mental Health (NIMH). Our understanding of this mysterious, disabling disorder in all its diversity has been enhanced by a host of technologies, including new neuroimaging techniques, cognitive psychology, molecular genetics, and anatomical, biochemical, and molecular neuropathology. The resulting growth spurt in our knowledge constitutes the essence of the conference and of this volume. As the following pages amply docu ment, it has been a decade of great progress, one in which we can take great pride. The science of our field has matured to the point that a major research thrust is now feasible-one likely to have enormous benefits for schizophrenic patients and their families. It is a very exciting time to be in this field and to participate in accelerating its advances.
Authors and Affiliations
-
Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, USA
Anthony Kales
-
Central Pennsylvania Psychiatric Institute, Pennsylvania State University College of Medicine, Hershey, USA
Anthony Kales
-
Department of Psychiatry, Athens University Medical School, Athens, Greece
Costas N. Stefanis
-
World Psychiatric Association, USA
Costas N. Stefanis
-
Department of Psychiatry, University of Maryland, School of Medicine, Baltimore, USA
John A. Talbott
-
Institute of Psychiatry and Human Behavior, University of Maryland Medical System, Baltimore, USA
John A. Talbott